Research and Markets: Threats and Opportunities in the Pharmaceutical Industry - 2012-2013 - Business Wire

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/76pt7t/threats_and_opport) has announced the addition of iCD Research's new report "Threats and Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Brief" to their offering.

“Threats and Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Brief”

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry executives. It analyzes the future business challenges in the pharmaceutical industry for 2012-13. This report gives you access to the category-level business challenges of leading purchase decision makers. The report also identifies future growth of buyers and suppliers. The report also provides access to information categorized by region, company type and size.

Scope:

- The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.

- The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.

- The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.

- In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.

- The report provides qualitative analysis of the key industry threats and opportunities.

Reasons To Buy:

This report will help you to...

- drive revenues by understanding future product investment areas and growth regions.

- better promote your business by aligning your capabilities and business practices with your customer's changing needs.

- secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.

- uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.

For more information visit http://www.researchandmarkets.com/research/76pt7t/threats_and_opport

Source: iCD Research

View the original article here

Research and Markets: Threats and Opportunities in the Pharmaceutical Industry - 2012-2013

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/76pt7t/threats_and_opport) has announced the addition of iCD Research's new report "Threats and Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Brief" to their offering.

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry executives. It analyzes the future business challenges in the pharmaceutical industry for 2012-13. This report gives you access to the category-level business challenges of leading purchase decision makers. The report also identifies future growth of buyers and suppliers. The report also provides access to information categorized by region, company type and size.

Scope:

- The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.

- The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.

- The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.

- In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.

- The report provides qualitative analysis of the key industry threats and opportunities.

Reasons To Buy:

This report will help you to...

- drive revenues by understanding future product investment areas and growth regions.

- better promote your business by aligning your capabilities and business practices with your customer's changing needs.

- secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.

- uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.

For more information visit http://www.researchandmarkets.com/research/76pt7t/threats_and_opport

Source: iCD Research

View the original article here

Research and Markets: The Impact of Generics on Pharmaceutical Growth Opportunities - A Growing Threat that Offers ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/52d660/the_impact_of_gene) has announced the addition of the "The Impact of Generics on Pharmaceutical Growth Opportunities - A Growing Threat that Offers Future Opportunities" report to their offering.

While generic penetration has been on the rise in the major developed markets for some time, the current and continuing difficult economic environment is stimulating political and payer actions to accelerate the trend.

Combined with this, pharma is experiencing a wave of blockbuster patent expiries, with almost $30 billion in US sales (at 2010 levels) exposed by the largest 10 drugs which are expected to experience generic competition for the first time in 2011-2012.

As a result, companies must focus on optimizing their late-stage lifecycle management strategies to maximize at-risk product revenues. But at the same, time generics should be considered not just as a threat but also as an opportunity going forward.

The report, The Impact of Generics on Pharmaceutical Growth Opportunities, has been written to support companies with their strategic plans to maximize revenues within the shifting pharmaceutical landscape. The insights, analysis, and support provided can be used by both the branded and generics side of the business.

Key Reasons to Purchase:

Compare your company's lifecycle management strategies with those most appropriate for maximizing generic defense Assess the opportunities available to move into the generics side of the pharmaceutical industry, both in the established and emerging markets Understand the various opportunities that exist to optimize revenue in preparation for your product's patent expiry Benefit from the analysis of multiple case studies to help support your company's/brand's strategy moving forward Learn from the assessments of actual tactics companies have taken, both branded & generic, to drive future revenue growth in this new era of generics

Key Topics Covered:

Executive summary

The impact of generics in 2011 and beyond

The impact of generics on the pharma market in 2010 Key events/trends impacting generic usage in the major pharmaceutical markets Key patent expiries in 2011 and 2012 Generics driving emerging market growth

Revenue optimization at patent expiry

Pediatric exclusivity Strategic pricing (including coupons and co-pay cards) Authorized generics Pay for delay deals Citizens petitions Reformulation and combination drugs Next generation drugs Prescription to over-the-counter switch

Generics as an opportunity

Big pharma with generics operations Emerging markets: a generics opportunity

For more information visit http://www.researchandmarkets.com/research/52d660/the_impact_of_gene

View the original article here